Summary
Updated Aug 31, 2026
Rachel Ellingson is Director of BIOLIFE SOLUTIONS INC (BLFS). 1 SEC Form 4 filing on record, dated 26 February 2026.
Recent Transactions
1Every recent SEC Form 4 transaction Rachel Ellingson has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Rachel Ellingson files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Casdin Partners Master Fund, L.P. - $49.54M of BLFS open-market activity in the last 12 months
- Greef Roderick de - $3.61M of BLFS open-market activity in the last 12 months
- Karen A. Foster - $2.06M of BLFS open-market activity in the last 12 months
- Troy Wichterman - $850K of BLFS open-market activity in the last 12 months
- Amy Duross - $257K of BLFS open-market activity in the last 12 months
- Aby J. Mathew - $56K of BLFS open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Rachel Ellingson?
Rachel Ellingson is a corporate insider, tracked as Director of BIOLIFE SOLUTIONS INC (BLFS). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Rachel Ellingson last file a Form 4?
The only primary Form 4 on record is dated 26 February 2026.
Where can I see all of Rachel Ellingson's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Rachel Ellingson and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
